Riot Acquires 13% Stake in Bitfarms Amid CEO’s ‘Poison Pill’ Concerns

Last Updated on June 13, 2024

Efe Headshot
Written by
Person holding cellphone with Riot Platforms Inc. on screen with logo. Source: Timon - stock.adobe.com

Key Takeaways:

  • Riot Platforms acquired a 13.1% stake in Bitfarms for over $111 million amidst a takeover attempt.
  • Bitfarms adopted a “poison pill” strategy to prevent Riot from acquiring a 15% or larger stake.
  • Riot’s CEO Jason Les criticized Bitfarms’ defense tactic, while Bitfarms insists it complies with Canadian securities laws.

Riot Platforms has acquired a 13.1% stake in Bitfarms, purchasing around six million common shares valued at over $111 million.

This acquisition comes amidst Riot’s takeover attempt, which Bitfarms is trying to thwart using a “poison pill” strategy introduced on June 10.

This strategy aims to prevent Riot from acquiring a 15% or larger stake by diluting the value of its shares.

Riot CEO Jason Les criticized Bitfarms’ defense tactic for setting the threshold at 15% instead of the typical 20%, claiming it conflicts with legal and governance standards.

Bitfarms maintains that its plan aligns with Canadian securities laws.

Riot had previously offered to buy Bitfarms for $950 million, a 24% premium over its one-month volume-weighted average share price.

Bitfarms’ stock price on the Nasdaq has surged over 56% in the past 30 days due to the takeover plans.

Additionally, Bitfarms’ former CEO, Geoffrey Morphy, resigned in May after suing the company, with Nicolas Bonta stepping in as interim president and CEO.

Les has called for Bonta’s removal, citing poor corporate governance.

About The Author

Efe Headshot
Written by

News Reporter

Efe Bravo, a seasoned journalist, delivers compelling insights into the cryptocurrency and blockchain industry.

His articles offer a deep dive into the latest trends, projects, and technological advancements shaping the future of digital finance.

Check Efe out on: